Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micronized DHACM in knee osteoarthritis
NCT05796765Phase 2Terminated
- Sponsor
- MIMEDX
- Start
- Mar 2023
- Primary completion
- Dec 2023
- Modality
- Implantable Devices, Implantable Hydrogels, Tissue Cells
- Countries
- 1
01
Overview
A Phase 2 trial of AmnioFix in osteoarthritis (OA), sponsored by MIMEDX. Started Mar 2023; status: terminated.
02
Drugs
AmnioFix
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05796765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05796765.